Simon Wilkins obtained Ph.D. degree in the biology of malaria in the mosquito from Imperial College, London, UK, in 1997. Following the first postdoctoral position on breast cancer, Wilkins worked on a varied theme of brain-related diseases including cerebral malaria, neurodegenerative eye diseases, and prion diseases. In 2009, Wilkins joined the Monash Institute of Medical Research to investigate a paediatric developmental disorder. Wilkins was also involved in two other projects, investigating trace elements as biomarkers for prostate cancer and studying the biochemical and molecular basis of cancers such as glioblastoma, medulloblastoma, and osteosarcoma. Wilkins joined Monash University at the Alfred Hospital in 2012 project managing of a number of clinical-quality blood disease registries, including thrombotic thrombocytopenic purpura, neonatal alloimmune thrombocytopenia, and a plastic anemia. In 2013, Wilkins took a short contract role as Ethics Expert for Servier Pharmaceuticals to assist establishment of a Phase IV trial. Wilkins' current position at Cabrini Institute involves research into bowel cancer with a multidisciplinary team of researchers and clinicians.
Biography Updated on 20 January 2014